Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists

被引：5

作者：

Kiyoi, Takao ^{[1
]}

Adam, Julia M. ^{[1
]}

Clark, John K. ^{[1
]}

Davies, Keneth ^{[1
]}

Easson, Anna-Marie ^{[1
]}

Edwards, Darren ^{[1
]}

Feilden, Helen ^{[1
]}

Fields, Ruth ^{[1
]}

Francis, Stuart ^{[1
]}

Jeremiah, Fiona ^{[1
]}

McArthur, Duncan ^{[1
]}

Morrison, Angus J. ^{[1
]}

Prosser, Alan ^{[1
]}

Ratcliffe, Paul D. ^{[1
]}

Schulz, Jurgen ^{[1
]}

Wishart, Grant ^{[1
]}

Baker, James ^{[2
]}

Campbell, Robert ^{[2
]}

Cottney, Jean E. ^{[2
]}

Deehan, Maureen ^{[2
]}

Epemolu, Ola ^{[2
]}

Evans, Louise ^{[2
]}

机构：

[1] Merck Res Labs, Dept Chem, MSD, Newhouse ML1 5SH, Lanark, Scotland

[2] Merck Res Labs, Dept Pharmacol, MSD, Newhouse ML1 5SH, Lanark, Scotland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 06期

关键词：

Cannabinoid; CB1 receptor agonist; Oral bioavailability; NITRILE SULFIDES; DRUG DISCOVERY; PAIN; INDOLE-3-CARBOXAMIDES; GENERATION; DESIGN; MODELS;

D O I：

10.1016/j.bmcl.2011.01.082

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel 3-(1H-indol-3-yl)-1,2,4-oxadiazoles and -thiadiazoles were synthesized and found to be potent CB1 cannabinoid receptor agonists. The oral bioavailability of these compounds could be dramatically improved by optimization studies of the side chains attached to the indole and oxadiazole cores, leading to identification of a CB1 receptor agonist with good oral activity in a range of preclinical models of antinociception and antihyperalgesia. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：1748 / 1753

页数：6

共 50 条

[21] The CB1 cannabinoid receptor in the brain
Howlett, AC
NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
[22] Cannabinoid CB1 Receptor Antagonists
Thomas, Brian F.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
[23] CB1 cannabinoid receptor ligands
Thakur, GA
Nikas, SP
Makriyannis, A
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
[24] CB1 cannabinoid receptor antagonists
Barth, F
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
[25] Discovery of novel diarylpyrazolyl thiadiazoles as cannabinoid CB1 receptor antagonists
Seo, Hee Jeong
Lee, Suk Ho
Lee, Sung-Han
Jung, Myung Eun
Ahn, Kwangwoo
Kim, Jeongmin
Lee, Jinhwa
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[26] Discovery of indole alkaloids with cannabinoid CB1 receptor antagonistic activity
Kitajima, Mariko
Iwai, Masumi
Kikura-Hanajiri, Ruri
Goda, Yukihiro
Iida, Mitsuru
Yabushita, Hisatoshi
Takayama, Hiromitsu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 1962 - 1964
[27] The Cannabinoid CB1 Receptor in Schizophrenia
Borgan, Faith
Kokkinou, Michelle
Howes, Oliver
BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
[28] Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists
Papanastasiou, Ioannis P.
Georgiadis, Markos-Orestis
Iliopoulos-Tsoutsouvas, Christos
Paronis, Carol A.
Brust, Christina A.
Tran, Ngan K.
Ji, Lipin
Ma, Xiaoyu
Wood, JodiAnne T.
Zvonok, Nikolai
Tong, Fei
Bohn, Laura M.
Nikas, Spyros P.
Makriyannis, Alexandros
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 230
[29] Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Shi, Jun
Gu, Zhengxiang
Jurica, Elizabeth Anne
Wu, Ximao
Haque, Lauren E.
Williams, Kristin N.
Hernandez, Andres S.
Hong, Zhenqiu
Gao, Qi
Dabros, Marta
Davulcu, Akin H.
Mathur, Arvind
Rampulla, Richard A.
Gupta, Arun Kumar
Jayaram, Ramya
Apedo, Atsu
Moore, Douglas B.
Liu, Heng
Kunselman, Lori K.
Brady, Edward J.
Wilkes, Jason J.
Zinker, Bradley A.
Cai, Hong
Shu, Yue-Zhong
Sun, Qin
Dierks, Elizabeth A.
Foster, Kimberly A.
Xu, Carrie
Wang, Tao
Panemangalore, Reshma
Cvijic, Mary Ellen
Xie, Chunshan
Cao, Gary G.
Zhou, Min
Krupinski, John
Whaley, Jean M.
Robl, Jeffrey A.
Ewing, William R.
Ellsworth, Bruce Alan
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 681 - 694
[30] Toward the Design of Cannabinoid CB1 Receptor Inverse Agonists and Neutral Antagonists
Reggio, Patricia H.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 585 - 600

← 1 2 3 4 5 →